Literature DB >> 23719141

[A suspected case of extra-gonadal germ cell tumor complicated with choriocarcinoma syndrome].

Masafumi Nakamura1, Takahiro Hanai, Hiroyuki Sanjyo, Kengo Yasuda, Daiji Takamoto, Ayako Gohbara, Jun-ichi Teranishi, Yasushi Yumura, Yasuhide Miyoshi, Keiichi Kondo, Kazumi Noguchi.   

Abstract

Our patient was a 31-year-old man who presented with right flank pain. Computed tomography revealed multiple tumors in the liver and lungs, with marked elevation of serum human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) levels. In addition, no testicular abnormalities were detected by palpation or ultrasonography. On the bases of these results, the patient was diagnosed with extragonadal germ cell tumor and was therefore started on chemotherapy with bleomycin, etoposide, and cisplatin (BEP). However, the result of a subsequent blood test showed marked pancytopenia at the initial stage of treatment. We speculated that the cause of anemia was not only bone marrow suppression but also intratumoral hemorrhage, collectively termed choriocarcinoma syndrome. After conservative treatment involving blood transfusion and administration of granulocyte colony-stimulating factor, he recovered. After several chemotherapy sessions, the levels of all tumor markers returned to normal. Finally, the patient underwent hepatectomy for residual tumors ; but, the resected specimen showed no viable cancer cells. Currently, the patient is free from disease since the last chemotherapy session, administered 5 months ago.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719141

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  1 in total

1.  Case of acute respiratory distress syndrome in a patient with an extragonadal germ cell tumor without lung metastasis in which choriocarcinoma syndrome was suspected.

Authors:  Kota Kobayashi; Sohgo Tsutsumi; Go Noguchi; Susumu Umemoto; Kimito Osaka; Takeshi Kisida
Journal:  IJU Case Rep       Date:  2019-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.